{"disease":{"id":"metabolic-dysfunction-associated-steatohepatitis-mash","name":"metabolic dysfunction associated steatohepatitis mash"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06741111","title":"A Real-world Assessment in Implementation of the MASH Patient Care Pathway in Chinese Population Using the Meinian Health Check-up Database","phase":"","overall_status":"COMPLETED","enrollment_count":1233970,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT06795646","title":"Clinical Classification of MAFLD Based Liver Biopsy","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT06632444","title":"LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":1800,"lead_sponsor_name":"Boehringer Ingelheim","has_results":false},{"nct_id":"NCT07476703","title":"Expanded Studies on the SCAPIS Stockholm Reexamination Cohort","phase":"","overall_status":"RECRUITING","enrollment_count":1400,"lead_sponsor_name":"Danderyd Hospital","has_results":false},{"nct_id":"NCT07201831","title":"A Multi-country, Cross-sectional Quantitative Study Exploring Awareness, Understanding, and Perceptions of the Relation Between Cardiorenal Metabolic Conditions and MASLD/MASH Among Healthcare Providers, People With MASLD/MASH, and At-risk Population","phase":"","overall_status":"COMPLETED","enrollment_count":1330,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT06647095","title":"New Non-invasive Biomarkers of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)","phase":"","overall_status":"COMPLETED","enrollment_count":172,"lead_sponsor_name":"General University Hospital, Prague","has_results":false},{"nct_id":"NCT06937749","title":"A Study of IBI362 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":165,"lead_sponsor_name":"Innovent Biologics (Suzhou) Co. Ltd.","has_results":false},{"nct_id":"NCT07145151","title":"A Study of UBT251 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":156,"lead_sponsor_name":"The United Bio-Technology (Hengqin) Co., Ltd.","has_results":false},{"nct_id":"NCT07466017","title":"A Study of CS060380 Tablets in Patients With MASH and Obesity","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Cascade Pharmaceuticals, Inc","has_results":false},{"nct_id":"NCT06374875","title":"Fibrosis Lessens After Metabolic Surgery","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Ali Aminian","has_results":false},{"nct_id":"NCT05519475","title":"A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false},{"nct_id":"NCT07013916","title":"Fructose is a Metabolic and Inflammatory Pathogenic Factor in Metabolic Dysfunction-associated Steatohepatitis (MASH)","phase":"NA","overall_status":"RECRUITING","enrollment_count":72,"lead_sponsor_name":"Queen Mary University of London","has_results":false},{"nct_id":"NCT06492330","title":"Efficacy and Safety of CS0159 Combined With Semaglutide in MASH Patients With Obesity and T2DM","phase":"NA","overall_status":"COMPLETED","enrollment_count":62,"lead_sponsor_name":"Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT07016633","title":"To Evaluate the Tolerability, Pharmacokinetics, and Pharmacodynamics of IMM-H014 in Patients With MASH","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"Changchun Intellicrown Pharmaceutical Co. LTD","has_results":false},{"nct_id":"NCT06675929","title":"A Study to Test How Well BI 770371 is Tolerated by People With Cirrhosis Caused by a Liver Disease Called MASH","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Boehringer Ingelheim","has_results":false},{"nct_id":"NCT07188220","title":"Patients' Perspectives on Metabolic Dysfunction-associated Steatohepatitis: a Qualitative Study","phase":"","overall_status":"RECRUITING","enrollment_count":25,"lead_sponsor_name":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","has_results":false},{"nct_id":"NCT07313007","title":"Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":24,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT06121999","title":"Behavioral Lifestyle Intervention for Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Adults","phase":"NA","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Grand Valley State University","has_results":false}],"total":18},"guidelines":[],"source":"Drug Landscape verified database"}